Clinical Trials in San Francisco

Showing 4621-4640 of 12,991 trials

Liver Transplantation With Tregs at UCSF

NCT03654040

This is a single-center, prospective, open-label, non-randomized clinical trial exploring cellular therapy to facilitate immunosuppression withdrawal in liver transplant recipients.

Liver Transplant

National Institute of Allergy and Infectious Diseases (NIAID)42 participantsStarted Apr 2021

San Francisco, California, United States

No Longer Available< 1 mile

Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS

NCT04681118

Expanded Access for treatment with investigational product MSC-NTF cells(NurOwn®) for participants who completed all scheduled treatments and follow-up assessments in the BCT-002-US study

Amyotrophic Lateral Sclerosis

Brainstorm-Cell Therapeutics

Irvine, California, United States • San Francisco, California, United States • Boston, Massachusetts, United States +2 more locations

Liver Transplantation With Tregs at UCSF

Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS

Find Trials by Condition in San Francisco

Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients

A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)

A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis

Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

Brain Oxygenation-II

StrokeCog-BBB to Study Cognitive Outcomes Following Stroke

Improving Outcomes Among Medical/Surgical Inpatients With Alcohol Use Disorders

Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility

Immune Modulation by Enhanced vs Standard Prehabilitation Program Before Major Surgery

Letrozole for Lymphangioleiomyomatosis

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma

Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology

Craniofacial Microsomia: Longitudinal Outcomes in Children Pre-Kindergarten (CLOCK)

SL-401 in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma

A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis

Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities